0001493152-23-009295.txt : 20230328 0001493152-23-009295.hdr.sgml : 20230328 20230328163658 ACCESSION NUMBER: 0001493152-23-009295 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230327 FILED AS OF DATE: 20230328 DATE AS OF CHANGE: 20230328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Myers Jeff Lynn CENTRAL INDEX KEY: 0001971112 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38892 FILM NUMBER: 23770103 MAIL ADDRESS: STREET 1: C/O BEYOND AIR, INC. STREET 2: 900 STEWART AVENUE, SUITE 301 CITY: GARDEN CITY STATE: NY ZIP: 11530 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Beyond Air, Inc. CENTRAL INDEX KEY: 0001641631 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 473812456 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 825 EAST GATE BOULEVARD, SUITE 320 CITY: GARDEN CITY STATE: NY ZIP: 11530 BUSINESS PHONE: 516-665-8200 MAIL ADDRESS: STREET 1: 825 EAST GATE BOULEVARD, SUITE 320 CITY: GARDEN CITY STATE: NY ZIP: 11530 FORMER COMPANY: FORMER CONFORMED NAME: AIT Therapeutics, Inc. DATE OF NAME CHANGE: 20170117 FORMER COMPANY: FORMER CONFORMED NAME: KokiCare, Inc. DATE OF NAME CHANGE: 20150507 4 1 ownership.xml X0407 4 2023-03-27 0 0001641631 Beyond Air, Inc. XAIR 0001971112 Myers Jeff Lynn 900 STEWART AVENUE, SUITE 301 GARDEN CITY NY 11530 0 1 0 0 Chief Medical Officer 0 Common Stock 2023-03-27 4 A 0 50000 0 A 50000 D Stock Option (right to buy) 6.14 2023-03-27 4 A 0 50000 0 A 2033-03-26 Common Stock 50000 50000 D Represents restricted stock units ("RSUs") granted on March 27, 2023 to acquire 50,000 shares of common stock of Beyond Air, Inc. (the "Issuer"). The RSUs will vest as to 20% of the shares of common stock underlying the RSUs on December 15, 2023, with the remainder vesting in equal annual installments on December 15 of each of the four ensuing years thereafter until vested in full, in each case subject to the reporting person's continued service with the Issuer. Each RSU represents the right to receive one share of common stock of the Issuer. The option will vest as to 25% of the shares of common stock underlying the option on March 27, 2024, with the remainder vesting in equal annual installments on March 27 of each of the three ensuing years thereafter until vested in full, in each case subject to the reporting person's continued service with the Issuer. /s/ Adam T. Newman, as attorney-in-fact 2023-03-28